Every cell in nature is bound by a gossamer membrane with relative dimensions akin to those of a rubber balloon filled with water. These membranes are made of two back-to-back layers comprising a blend of jiggling lipid molecules-the so-called "lipid bilayer"-and in most organisms, the predominant ingredients in the lipid blend are the glycerophospholipids.
The obvious inference was that these variant enzymes were PtdThr synthases (PTSs). To confirm the notion, the authors disrupted the PTS gene in Toxo, finding that this wiped out all PtdThr synthesis; showing that PTS is entirely responsible for making PtdThr; reintroducing an intact PTS gene gratifyingly reinstated PtdThr synthesis.
But does PtdThr matter for Toxo? The authors compared how the PTS mutant and the rescued strain fared in cultured human fibroblast host cells. Normally, the Toxo infection results in clear patches of host cell destruction called plaques, which in essence represent successive lytic cycles. Mutating the PTS gene dramatically reduced the size and number of plaques, while reinstating the functional enzyme rescued this effect. To find out why Toxo needed the exotic lipid, the authors dissected the mutant's poor growth phenotype. Unexpectedly, the authors discovered that the parasite replication was normal; however, the exit from host cells was impaired, and invasion of new host cells was also compromised (Fig 1) . Consistently, calciumregulated gliding movement of the parasite that is needed for both entry and exit was halved. Because PtdThr's close cousin PtdSer has been described to regulate calcium storage and signaling, the authors speculate that Toxo may have evolved PtdThr as a specialized variant of PtdSer to modulate calcium during its entry and exit to and from host cells.
To see whether the defects observed in a culture dish are relevant to a real-life Toxo infection, the authors injected mice with the PTS mutant parasites. Not only were the mutant Toxo completely avirulent but they also acted as an effective metabolically-attenuated vaccine, conferring 100% resistance to subsequent challenge infection by parasite strains that normally cause acute and chronic infections.
In a nutshell, the authors show that an unusual lipid, previously only found in trace amounts in nature, is highly abundant in the membranes of a clinically important and widespread parasitic protist. Interestingly, for a lipid that is clearly crucial for the lifecycle and virulence of Toxo, the parasite has not only evolved a special enzyme to make PtdThr, but possibly also a pathway to make its own threonine-an amino acid that we humble humans have to obtain from our diet.
Toxo is likely not alone in its idiosyncratic lipid requirements. The presence of closely related PTS sequences in other globally prevalent apicomplexans like Eimeria and Neospora species and in more distant organisms, such as Phytophthora infestans (the critter responsible for the great Irish potato famine) suggests that PtdThr may not be as exotic as we previously believed. In Toxo and its parasitic relatives, the dependence of these common pathogens on an enzyme and lipid that their hosts lack opens up a potential opportunity for drug and vaccine development to target this Achilles heel.
